Simple and safe: preventing preterm birth with aspirin

Affiliations

¹ Institute for Health Research, University of Notre Dame Australia, Fremantle, WA, Australia; School of Medicine, Australia National University, Canberra, ACT, Australia. Electronic address: julie.quinlivan@nd.edu.au.

Comment

Julie A Quinlivan. Lancet. 2020.

. 2020 Jan 25;395(10220):250-252.

doi: 10.1016/S0140-6736(20)30106-9.

¹ Institute for Health Research, University of Notre Dame Australia, Fremantle, WA, Australia; School of Medicine, Australia National University, Canberra, ACT, Australia. Electronic address: julie.quinlivan@nd.edu.au.

No abstract available

Comment on

Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial.
Hoffman MK, Goudar SS, Kodkany BS, Metgud M, Somannavar M, Okitawutshu J, Lokangaka A, Tshefu A, Bose CL, Mwapule A, Mwenechanya M, Chomba E, Carlo WA, Chicuy J, Figueroa L, Garces A, Krebs NF, Jessani S, Zehra F, Saleem S, Goldenberg RL, Kurhe K, Das P, Patel A, Hibberd PL, Achieng E, Nyongesa P, Esamai F, Liechty EA, Goco N, Hemingway-Foday J, Moore J, Nolen TL, McClure EM, Koso-Thomas M, Miodovnik M, Silver R, Derman RJ; ASPIRIN Study Group. Hoffman MK, et al. Lancet. 2020 Jan 25;395(10220):285-293. doi: 10.1016/S0140-6736(19)32973-3. Lancet. 2020. PMID: 31982074 Free PMC article. Clinical Trial.